Immediate Impact
49 standout
Citing Papers
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Works of Adrián Sousa being referenced
Ceftazidime–avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae
2022
Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Adrián Sousa | 126 | 176 | 24 | 128 | 28 | 309 | |
| Bruce Dalton | 117 | 99 | 36 | 132 | 28 | 363 | |
| Daniel Eiras | 106 | 141 | 4 | 115 | 14 | 361 | |
| Mordechai Grupper | 134 | 174 | 29 | 136 | 17 | 342 | |
| Filippo Del Puente | 142 | 98 | 25 | 88 | 32 | 333 | |
| Mario Cepparulo | 133 | 134 | 6 | 55 | 21 | 366 | |
| Jeffrey S Loutit | 137 | 192 | 6 | 192 | 12 | 347 | |
| Evangelos Vryonis | 72 | 184 | 23 | 98 | 11 | 284 | |
| Huang-Shen Lin | 114 | 100 | 37 | 53 | 21 | 283 | |
| Luigi Ronga | 135 | 136 | 47 | 111 | 36 | 335 | |
| Kenta Ito | 124 | 57 | 33 | 53 | 31 | 311 |
All Works
Login with ORCID to disown or claim papers
Loading papers...